Release Thursday June 15, 8:30 am ET:  

Program to Feature Prominent MS Experts Discussing;

Tysabri and What It Means for Consumers

 SEATTLE, June 15 /PRNewswire/ --

WHAT:

HealthTalk Inc., a pioneer in patient education delivering live and web-based programs on the latest treatments and research news, is hosting a live webcast for Multiple Sclerosis patients, their families, and caregivers.  Experts will be discussing the recall and the re-approval of the drug Tysabri as well as its benefits, safety, and risk management.  Consumers can participate via the live webcast or by phone. 

WHY:

There are more than 400,000 people who have been diagnosed with Multiple Sclerosis in the U.S.  The drug Tysabri has recently been approved by the FDA for re-release for use in patients with relapsing forms of MS. 

WHO:

Howard Rossman, D.O., F.A.C.N. 

Dr.  Rossman spearheaded the creation of the M.I.N.D. Multiple Sclerosis Center located in Farmingham Hills, MI; and serves as Medical Director of the Center which presently services over 1,800 patients with MS. 

WHEN:

Thursday, June 22nd 2006 8:30 PM (Eastern) 5:30 PM (Pacific)

WHERE:

Register online at: www.healthtalk.com/msprogram  or call 1-800-522-3254. 

COST:

Free

Press Contact: Alyssa Schaier, 914-589-6904 aschaier@informedmedical.com

Source:

HealthTalk Inc.